Figure S1-3, Table S1-4 from Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
Fumihiko Urabe(Jikei University School of Medicine), Takahiro Ochiya(Unknown), Tomohiko Hara(National Cancer Research Institute), Hiroyuki Fujimoto(Tokyo National Hospital), Shumpei Niida(National Center for Geriatrics and Gerontology), Ken Kato(National Cancer Center Hospital East), Satoko Takizawa(Toray Industries, Inc. (Japan)), Yusuke Yamamoto, Takahiro Kimura(Jikei University School of Medicine), Makiko Ichikawa(Toray Industries, Inc. (Japan)), Hiromi Sakamoto(National Cancer Centre Japan), Juntaro Matsuzaki(Keio University), Yoshiaki Aoki, Shinichi Egawa(Tohoku University)
Cited by 0
Related Papers
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis
|Journal of Biological Chemistry|2013|770
Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier
|Nature Communications|2015|706